arrow_back Trending Legislation
Share share

Securing Military Drug Supply: Assessing Foreign Pharmaceutical Risk.

This law aims to strengthen the security of essential drug supplies for the Department of Defense (DoD). It mandates the military to prepare a detailed report on its reliance on foreign suppliers for pharmaceutical ingredients, particularly those from high-risk countries. While directly focused on the military, the goal is to enhance national pharmaceutical security, indirectly contributing to supply stability during crises.
Key points
Requires a report analyzing the extent to which the Department of Defense relies on foreign suppliers for key pharmaceutical ingredients.
Mandates updating risk management guidelines for the military drug supply chain to reduce vulnerability to disruptions.
The DoD must rely on the Food and Drug Administration (FDA) determinations regarding drug components.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Pharmaceutical Risk Assessment and Mitigation Act of 2024
Print number: S 4635
Sponsor: Sen. Peters, Gary C. [D-MI]
Process start date: 2024-07-08
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-flash-latest
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about Securing Military Drug Supply: Assessing Foreign Pharmaceutical Risk.

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is S 4635.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2024-07-08.

What are the main provisions?

Key points include:

  • Requires a report analyzing the extent to which the Department of Defense relies on foreign suppliers for key pharmaceutical ingredients.
  • Mandates updating risk management guidelines for the military drug supply chain to reduce vulnerability to disruptions.
  • The DoD must rely on the Food and Drug Administration (FDA) determinations regarding drug components.

What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Peters, Gary C. [D-MI].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-26.

Analysis and Potential Impact of S 4635

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Security Health